SELLAS Life Sciences Group, Inc. (SLS) Tops Q1 EPS by 2c

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) reported Q1 EPS of ($0.21), $0.02 better than the analyst estimate of ($0.23).

For earnings history and earnings-related data on SELLAS Life Sciences Group, Inc. (SLS) click here.

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• Delta Air Lines stock climbs on earnings beat and strong guidance
• Delta Air shares slip despite strong outlook, Melius says